FR2759699B1 - Derives de 5-(2,3-dihydro-1,4-benzoxazin-5-yl)-3-(piperidin- 4-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique - Google Patents

Derives de 5-(2,3-dihydro-1,4-benzoxazin-5-yl)-3-(piperidin- 4-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique

Info

Publication number
FR2759699B1
FR2759699B1 FR9701991A FR9701991A FR2759699B1 FR 2759699 B1 FR2759699 B1 FR 2759699B1 FR 9701991 A FR9701991 A FR 9701991A FR 9701991 A FR9701991 A FR 9701991A FR 2759699 B1 FR2759699 B1 FR 2759699B1
Authority
FR
France
Prior art keywords
benzoxazin
oxadiazol
piperidin
therapeutics
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9701991A
Other languages
English (en)
Other versions
FR2759699A1 (fr
Inventor
Samir Jegham
Alistair Lochead
Alain Nedelec
Axelle Solignac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR9701991A priority Critical patent/FR2759699B1/fr
Publication of FR2759699A1 publication Critical patent/FR2759699A1/fr
Application granted granted Critical
Publication of FR2759699B1 publication Critical patent/FR2759699B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR9701991A 1997-02-20 1997-02-20 Derives de 5-(2,3-dihydro-1,4-benzoxazin-5-yl)-3-(piperidin- 4-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique Expired - Fee Related FR2759699B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9701991A FR2759699B1 (fr) 1997-02-20 1997-02-20 Derives de 5-(2,3-dihydro-1,4-benzoxazin-5-yl)-3-(piperidin- 4-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9701991A FR2759699B1 (fr) 1997-02-20 1997-02-20 Derives de 5-(2,3-dihydro-1,4-benzoxazin-5-yl)-3-(piperidin- 4-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2759699A1 FR2759699A1 (fr) 1998-08-21
FR2759699B1 true FR2759699B1 (fr) 1999-03-19

Family

ID=9503947

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9701991A Expired - Fee Related FR2759699B1 (fr) 1997-02-20 1997-02-20 Derives de 5-(2,3-dihydro-1,4-benzoxazin-5-yl)-3-(piperidin- 4-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique

Country Status (1)

Country Link
FR (1) FR2759699B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580885A (en) * 1991-09-12 1996-12-03 Smithkline Beecham P.L.C. 5-HT4 receptor antagonists
WO1995032965A1 (fr) * 1994-06-01 1995-12-07 Yamanouchi Pharmaceutical Co. Ltd. Derive de l'oxadiazole et composition medicinale a base de ce dernier

Also Published As

Publication number Publication date
FR2759699A1 (fr) 1998-08-21

Similar Documents

Publication Publication Date Title
IL124364A (en) 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol -2(3h)- one derivatives, their preparation and pharmaceutical compositions comprising them
IL140236A (en) 1,3-oxazoline and 1,3-thiazoline derivatives, their preparation and insecticidal, acaridical or nematicidal compositions comprising them
DE19983463T1 (de) Polyoxymethylencopolymeres und eine dieses enthaltende Zusammensetzung
FR2809732B1 (fr) DERIVES DE 4(-2-PHENYLTHIAZOL-5-yl)-1,4-DIAZABICYCLO-[3.2.2] NONANE, LEUR PREPARATION ET LEUR APPLICATION ENTHERAPEUTIQUE
HUP9904032A3 (en) 1,2,4-benzothiadiazine derivatives,their preparation and use
FR2728900B1 (fr) Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique
IL87339A0 (en) 2-((4-piperidyl)methyl)-1,2,3-4-tetrahydroisoquinoline derivatives,their preparation and their application in therapy
ZA988921B (en) 3,4-diarylthiazolin-2-one or -2-thione derivatives their methods of preparation and their uses in therapeutics
FR2762316B1 (fr) Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
FR2724935B1 (fr) Compositions nanoparticulaires contenant des derives nucleotidiques, leur preparation et leur emploi en therapeutique
ZA9811217B (en) 7-[3-[4(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and allergy.
FI945562A7 (fi) 1,3,4-oksadiatsol-2(3H)-onijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FR2763067B1 (fr) Derives de 3-(1-azabicyclo[2.2.2] oct-3-ylalkyl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
FR2765581B1 (fr) Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
FR2761068B1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
FR2745574B1 (fr) Derives de 5-phenyl-3-(piperidin-4-yl)-1, 3, 4-oxadiazol-2 (3h)-one, leur preparation et leur application en therapeutique
FR2763068B1 (fr) Derives de 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
FR2653122B1 (fr) Derives de 5-[2-[[2-amino-2-oxoethyl]methylamino]ethyl]-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5(5h)-benzothiazepine-4-one, leur preparation et leur application en therapeutique.
BR9506518A (pt) Derivados de 3-aril-alquenil- 1,2,4-oxadiazol
FR2741069B1 (fr) Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h) -one, leur preparation et leur application en therapeutique
FR2741070B1 (fr) Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h) -one, leur preparation et leur application en therapeutique
FR2763069B1 (fr) Derives de 1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
FR2741072B1 (fr) Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
DE69805207D1 (de) Bodenbearbeitungsgerät mit stiel und spitze

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20051031